1. OC.02.5 THE RATE OF PANCREATIC ABNORMALITIES DETECTED BY MAGNETIC RESONANCE IN HIGH RISK INDIVIDUALS UNDER SURVEILLANCE FOR THE RISK OF PANCREATIC CANCER IS NOT DIFFERENT FROM THAT OF CONTROLS. (25th March 2019) Authors: Signoretti, M.; Martini, I.; Iannicelli, E.; Laghi, A.; Capurso, G. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P.02.4 REASSESSMENT OF HISTOLOGICAL FEATURES AT DISEASE PROGRESSION DURING THE FOLLOW-UP OF NEUROENDOCRINE TUMOURS. (24th February 2016) Authors: Cicchese, N.; Pilozzi, E.; Rinzivillo, M.; Iannicelli, E.; Panzuto, F.; Merola, E.; Pucci, E.; Capurso, G.; Delle Fave, G. Journal: Digestive and liver disease Issue: Volume 48(2016)Supplement 2 Page Start: e135 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P.03.1 PROGNOSTIC IMPACT OF TUMOR BURDEN IN STAGE IV NEUROENDOCRINE NEOPLASIA: COMPARISON BETWEEN PANCREATIC AND GASTROINTESTINAL LOCALIZATIONS. (25th March 2019) Authors: Panzuto, F.; Campana, D.; Pusceddu, S.; Faggiano, A.; Rinzivillo, M.; Brighi, N.; Prinzi, N.; Riccardi, F.; Iannicelli, E.; Maggio, I.; Fermia, D.; Tafuto, S.; Manuzzi, L.; Colao, A.; De Braud, F.; Annibale, B. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e163 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P.03.12 TEXTURE ANALYSIS ON CONTRAST-ENHANCED COMPUTED TOMOGRAPHY IN LIVER METASTASES FROM PANCREATIC AND NON-PANCREATIC NEUROENDOCRINE NEOPLASIA. (25th March 2019) Authors: Martini, I.; Magi, L.; Polici, M.; Rinzivillo, M.; Annibale, B.; Laghi, A.; Panzuto, F.; Iannicelli, E. Journal: Digestive and liver disease Issue: Volume 51(2019)Supplement 2 Page Start: e168 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P.04.12 ROLE OF CYST FEATURES AND PATIENTS' FACTORS IN PREDICTING THE RISK OF PROGRESSION IN BD-IPMN UNDERGOING FOLLOW-UP. Issue 2 (15th March 2018) Authors: Zerboni, G.; Vanella, G.; Stigliano, S.; Archibugi, L.; Signoretti, M.; Valente, R.; Iannicelli, E.; Fave, G. Delle; Capurso, G. Journal: Digestive and liver disease Issue: Volume 50:Issue 2(2018)Supplement Page Start: e160 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Sarcopenia at First Diagnosis Predicts a Reduced Survival in Patients Affected by Hepatocarcinoma. (15th February 2015) Authors: Antonelli, G.; Begini, P.; Gigante, E.; Carbonetti, F.; Iannicelli, E.; Gallina, S.; Pellicelli, A.; Miglioresi, L.; Fave, G. Delle; Marignani, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e63 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. SARCOPENIA IS ASSOCIATED WITH A REDUCED SURVIVAL IN PATIENTS WITH HEPATOCARCINOMA UNDERGOING SORAFENIB TREATMENT. (15th February 2015) Authors: Gigante, E.; Antonelli, G.; Begini, P.; Carbonetti, F.; Iannicelli, E.; Marchetti, P.; Miglioresi, L.; Pellicelli, A.; Fave, G. Delle; Marignani, M. Journal: Digestive and liver disease Issue: Volume 47(2015)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sarcopenia predicts survival in patients with advanced hepatocellular carcinoma treated with sorafenib. Issue 1 (February 2018) Authors: Antonelli, G.; Gigante, E.; Iavarone, M.; Begini, P.; Sangiovanni, A.; Iannicelli, E.; Biondetti, P.; Pellicelli, A.M.; Miglioresi, L.; Marchetti, P.; Lampertico, P.; Marignani, M. Journal: Digestive and liver disease Issue: Volume 50:Issue 1(2018)Supplement Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗